194 related articles for article (PubMed ID: 30275410)
1. Association of Uremic Toxins and Inflammatory Markers with Physical Performance in Dialysis Patients.
Pajek M; Jerman A; Osredkar J; Ponikvar JB; Pajek J
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30275410
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
Yamamoto S
Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
[TBL] [Abstract][Full Text] [Related]
3. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
[TBL] [Abstract][Full Text] [Related]
4. Composite Uremic Load and Physical Performance in Hemodialysis Patients: A Cross-Sectional Study.
Vanden Wyngaert K; Van Craenenbroeck AH; Holvoet E; Calders P; Van Biesen W; Eloot S
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32098304
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
[TBL] [Abstract][Full Text] [Related]
6. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.
Jourde-Chiche N; Dou L; Cerini C; Dignat-George F; Brunet P
Semin Dial; 2011; 24(3):327-37. PubMed ID: 21682773
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.
Eloot S; Van Biesen W; Roels S; Delrue W; Schepers E; Dhondt A; Vanholder R; Glorieux G
PLoS One; 2017; 12(10):e0186010. PubMed ID: 29016645
[TBL] [Abstract][Full Text] [Related]
8. Isolated Effects of Renal Failure, Anthropometric Indices, and Serum Total Iron-Binding Capacity as Determinants of Muscle Performance in Hemodialysis Patients.
Bučar Pajek M; Svilan K; Vivoda T; Škoberne A; Pajek J
J Ren Nutr; 2016 Jul; 26(4):245-52. PubMed ID: 26827132
[TBL] [Abstract][Full Text] [Related]
9. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
Taki K; Tsuruta Y; Niwa T
Am J Nephrol; 2007; 27(1):30-5. PubMed ID: 17215572
[TBL] [Abstract][Full Text] [Related]
10. Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis.
Delanaye P; Bataille S; Quinonez K; Buckinx F; Warling X; Krzesinski JM; Pottel H; Burtey S; Bruyère O; Cavalier E
J Ren Nutr; 2019 Nov; 29(6):511-520. PubMed ID: 30686748
[TBL] [Abstract][Full Text] [Related]
11. A Novel Uremic Score Reflecting Accumulation of Specific Uremic Toxins More Precisely Predicts One-Year Mortality after Hemodialysis Commencement: A Retrospective Cohort Study.
Arai Y; Shioji S; Tanaka H; Katagiri D; Hinoshita F
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019590
[TBL] [Abstract][Full Text] [Related]
12. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
[TBL] [Abstract][Full Text] [Related]
13. From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression.
Stockler-Pinto MB; Soulage CO; Borges NA; Cardozo LFMF; Dolenga CJ; Nakao LS; Pecoits-Filho R; Fouque D; Mafra D
Int Urol Nephrol; 2018 Feb; 50(2):347-354. PubMed ID: 29151180
[TBL] [Abstract][Full Text] [Related]
14. Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate.
Paats J; Adoberg A; Arund J; Fridolin I; Lauri K; Leis L; Luman M; Tanner R
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807387
[TBL] [Abstract][Full Text] [Related]
15. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis.
Segura-Ortí E; Martínez-Olmos FJ
Phys Ther; 2011 Aug; 91(8):1244-52. PubMed ID: 21719637
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging.
Taaffe DR; Harris TB; Ferrucci L; Rowe J; Seeman TE
J Gerontol A Biol Sci Med Sci; 2000 Dec; 55(12):M709-15. PubMed ID: 11129392
[TBL] [Abstract][Full Text] [Related]
17. Higher serum beta2-microglobulin levels are associated with better survival in chronic hemodialysis patients: a reverse epidemiology.
Kim KM; Kim SS; Kim H; Koo T; Im EY; Kim SB
Clin Nephrol; 2011 May; 75(5):458-65. PubMed ID: 21543026
[TBL] [Abstract][Full Text] [Related]
18. Normal and pathologic concentrations of uremic toxins.
Duranton F; Cohen G; De Smet R; Rodriguez M; Jankowski J; Vanholder R; Argiles A;
J Am Soc Nephrol; 2012 Jul; 23(7):1258-70. PubMed ID: 22626821
[TBL] [Abstract][Full Text] [Related]
19. An update on uremic toxins.
Neirynck N; Vanholder R; Schepers E; Eloot S; Pletinck A; Glorieux G
Int Urol Nephrol; 2013 Feb; 45(1):139-50. PubMed ID: 22893494
[TBL] [Abstract][Full Text] [Related]
20. Integrative Examination of Motor Abilities in Dialysis Patients and Selection of Tests for a Standardized Physical Function Assessment.
Bučar Pajek M; Leskošek B; Vivoda T; Svilan K; Čuk I; Pajek J
Ther Apher Dial; 2016 Jun; 20(3):286-94. PubMed ID: 27312917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
